Enterprise Value
223.4M
Cash
95.26M
Avg Qtr Burn
-10.39M
Short % of Float
1.95%
Insider Ownership
39.96%
Institutional Own.
54.72%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Epetraborole Details Mycobacterium avium complex lung disease, Lung disease | Phase 2/3 Data readout |